Document
IPR2017-00190, No. 2068-114 Exhibit - Kaken Exhibit 2068 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2068-114 Exhibit - Kaken Exhibit 2068 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2043-90 Exhibit - Kaken Exhibit 2043 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2043-90 Exhibit - Kaken Exhibit 2043 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1603-252 Exhibit - Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2013 (P.T.A.B....
Cite Document
IPR2017-00190, No. 1603-252 Exhibit - Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2013 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1623-272 Exhibit - An Exploratory Study to Improve Sales Operations When Selling Multiple Prescription Drugs (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1623-272 Exhibit - An Exploratory Study to Improve Sales Operations When Selling Multiple Prescription Drugs (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1606-255 Exhibit - Secondary Considerations of Nonobviousness Analysis The Use of Objective Indicia Following KSR v Teleflex, 86 NYU L Rev 2070 (P.T.A.B. Nov. 1, 2017...
Cite Document
IPR2017-00190, No. 1606-255 Exhibit - Secondary Considerations of Nonobviousness Analysis The Use of Objective Indicia Following KSR v Teleflex, 86 NYU L Rev 2070 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2069-115 Exhibit - Kaken Exhibit 2069 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2069-115 Exhibit - Kaken Exhibit 2069 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1033-33 Exhibit - J of the American Academy of Dermatology, 40 SupplS21¿¿¿6 1999 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1033-33 Exhibit - J of the American Academy of Dermatology, 40 SupplS21¿¿¿6 1999 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1503-149 Exhibit - Guidelines for treatment of onychomycosis (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1503-149 Exhibit - Guidelines for treatment of onychomycosis (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1590-239 Exhibit - Consolidated Financial Results for Fiscal 2016 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1590-239 Exhibit - Consolidated Financial Results for Fiscal 2016 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2018-64 Exhibit - Kaken Exhibit 2018 (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00190, No. 2018-64 Exhibit - Kaken Exhibit 2018 (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1032-32 Exhibit - Aly, R, J Am Acad Dermatol, 31S21¿¿¿S25 1994 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1032-32 Exhibit - Aly, R, J Am Acad Dermatol, 31S21¿¿¿S25 1994 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1507-155 Exhibit - PUBLIC VERSION Deposition Transcript of Vincent A Thomas (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1507-155 Exhibit - PUBLIC VERSION Deposition Transcript of Vincent A Thomas (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2009-55 Exhibit - Kaken Exhibit 2009 (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00190, No. 2009-55 Exhibit - Kaken Exhibit 2009 (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1667-322 Exhibit - Prosecution History of US Pat App No 15,405,171 (P.T.A.B. Jan. 5, 2018)
Cite Document
IPR2017-00190, No. 1667-322 Exhibit - Prosecution History of US Pat App No 15,405,171 (P.T.A.B. Jan. 5, 2018)
+ More Snippets
Document
IPR2017-00190, No. 1533-182 Exhibit - Beyond Valeant, US Payers Scrutinize Other Drugmaker Ties to Pharmacies,¿¿¿ D Beasley, Reuters, Health News, October 30, 2015 (P.T.A.B. Nov. 1, 201...
Cite Document
IPR2017-00190, No. 1533-182 Exhibit - Beyond Valeant, US Payers Scrutinize Other Drugmaker Ties to Pharmacies,¿¿¿ D Beasley, Reuters, Health News, October 30, 2015 (P.T.A.B. Nov. 1, 2017)
+ More Snippets